FDA advisers have recommended the approval of Guardant Health's blood test to detect colon or rectal cancers — but it also raised some concerns, NBC News reported May 23.
The Latest
A recent study from the University of Miami's Sylvester Comprehensive Cancer Center found that women oncologists who graduated from international medical schools report experiencing roughly 10 times as much discrimination as their male counterparts.
UC San Francisco is launching the first long-term study of cancer among Asian Americans.
The Markey Cancer Center in Lexington, Ky., part of the University of Kentucky, has inked a new partnership with Ukraine's Kyiv Regional Oncology Dispensary, according to a May 22 news release.
Oncologist depression rates remained steady compared to 2023, hovering around 20%, according to a Medscape report.
Administering more treatments to advanced, end-of-life cancer patients did not increase their length of survival, according to a joint study from researchers at Yale Cancer Center in New Haven, Conn., and the University of Texas MD Anderson Cancer Center in…
More hospitals and systems are testing the effectiveness of blood tests to detect cancer.
Minneapolis-based Allina Health launched a cancer mobile app that provides breast cancer patients with information to navigate their diagnosis and treatment.
Blood Centers of America will partner with Galapagos to help manufacture the Belgian biotech firm's CAR-T cell therapies, the companies said May 15.
In 2024, more than 2 million new cancer cases are projected to be diagnosed, and more than 611,700 deaths from cancer are expected, a May American Association of Cancer Research report found.